ORIC · Oric Pharmaceuticals, Inc.
AI read · Good for ORIC
The AI's read
The results give Oric evidence that enozertinib may shrink tumors, including in the brain. The study included only 26 patients, and lasting benefit is not yet known. A much larger trial is planned, so success remains unproven.